SPUTNIK LIGHT, THE FIRST COMPONENT OF SPUTNIK V, IS A SAFE AND EFFECTIVE STAND-ALONE ONE-SHOT VACCINE AGAINST COVID-19 AND AN IDEAL BOOSTER Efficacy against infection of over 80% Efficacy as a stand-alone vaccine against infection by Delta - 70% ...
单组分的“卫星Light”疫苗已在印度批准;有25亿人住在批准“卫星Light”作为独立疫苗和通用加强剂的国家。 06.02.2022 Press release “Sputnik Light”单组分疫苗在俄罗斯注册 06.05.2021 Press release 小型初步实验室研究显示:俄“卫星V”疫苗产生的奥密克戎抗体水平高于辉瑞 ...
HV公司向华兰疫苗转移伽马勒研究所Sputnik-V vaccine 5L/200L培养规模的生产技术，华兰疫苗在该技术基础上进行2500L培养规模的生产技术开发，生产技术开发成功后HV公司向华兰疫苗下达许可产品生产订单，订单数量不低于1亿剂（5000万人
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russi,Published:February02, 2021 DOI:https://doi.org/10.1016/S0140-6736(21)00234-8 文章结果写道,在2020年9月7日至11月24日期间,...
Russia's Sputnik V coronavirus vaccine is 95-percent effective, according to a second interim analysis of clinical trial data, its developers said on Tuesday.The calculations were based on preliminary data obtained 42 days after the first dose, Russia's Health Ministry, Gamaleya Scientific Re...
The Sputnik V vaccine's efficacy is confirmed at 91.4% based on data analysis of the final control point of clinical trials, Russian Direct Investment Fund (RDIF) 在接受第一剂疫苗或安慰剂后第21天,达到试验的第三个和最后一个...
同花顺（300033）金融研究中心5月10日讯，有投资者向华兰生物（002007）提问， 董秘，您好，请问与俄罗斯新冠疫苗合作项目，贵司是否有现成的车间使用？正式协议签署后，什么时间能够实现销售？公司回答表示，目前华兰基因工程有限公司的现有生产车间具备Sputnik-V vaccine的研发和生产条件，华兰生物疫苗股份有限公司相关...
The vaccine was registered under the emergency use authorisation procedure and was approved by the regulator, ANMAT, based on the results of Phase III clinical trials in Russia, without additional trials in Argentina.On December 10, RDIF and the Government of Argentina signed a contract for the ...
The approach taken towards production and administering of the vaccine should be based on the best available technologies, whilst making sure the vaccine is available equitably across the world. Countries need to construct a diverse vaccine portfolio, and the Russian vaccine, Sputnik V, should be ...
The Sputnik V vaccine is based on a proven and well-studied platform of human adenoviral vectors, which cause the common cold and have been around for thousands of years. Sputnik V uses two different vectors for the two shots in a course of vaccination, providing immunity with a longer durat...